Drug Delivery and Translational Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.9 | Q1 | 90.7% | 1.280 | Q1 | 89.4% |
| 2024 | 5.5 | Q1 | 90.7% | 1.175 | Q1 | 88.0% |
| 2023 | 5.7 | Q1 | 92.2% | 0.994 | Q1 | 85.4% |
| 2022 | 5.4 | Q1 | 85.2% | 0.810 | Q1 | 80.9% |
| 2021 | 5.7 | Q1 | 82.9% | 0.808 | Q1 | 81.4% |
| 2020 | — | — | 0.732 | Q2 | 77.4% | |
| 2019 | — | — | 0.627 | Q2 | 73.9% | |
| 2018 | — | — | 0.827 | Q1 | 79.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2190-393X
ISSN
2190-3948
region
Northern America
coverage
2011-2026